Safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive advanced breast cancer: Primary results from the KAMILLA study cohort 1

Montemurro, F; Ellis, P; Anton, A; Wuerstlein, R; Delaloge, S; Bonneterre, J; Quenel-Tueux, N; Linn, SC; Irahara, N; Donica, M; Lindegger, N; Barrios, CH

Montemurro, F (reprint author), FPO IRCCS, Invest Clin Oncol INGO, Candiolo Canc Inst, Prov Rd 142, I-10060 Turin, Italy.

EUROPEAN JOURNAL OF CANCER, 2019; 109 (): 92

Abstract

Background: Many patients with metastatic human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC) are candidates for trastuzumab e......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索